Other top stories

Early Trauma Linked to More Pain and Loneliness at Life’s End

October 7, 2024

Anxiety Grips Voters as Election Day Looms

October 4, 2024

Weekly Mind Reader: The Digital Era’s Impact on Mental Health

October 4, 2024

The History of Dopaminergic Blockade in Schizophrenia

October 4, 2024

Beyond Dopamine: Evaluating the Pipeline for Schizophrenia

October 4, 2024

Xanomeline-Trospium and Iclepertin Show Promise in Managing Cognitive Impairment in Schizophrenia

October 4, 2024

Other stories

Schizophrenia’s Acute Psychosis Crisis Calls for Novel Treatments

October 4, 2024

A Third of Former NFL Players Believe They Have CTE

October 3, 2024

Xanomeline-Trospium Shows Promise in Schizophrenia with Fewer Side Effects

October 3, 2024

Evaluating Pooled Data from the EMERGENT Study Programs

October 3, 2024

Study Links Conversion Therapy to Increased PTSD, Other Issues

October 2, 2024

Study Highlights Increased Mortality Risks in Difficult-to-Treat Depression

October 1, 2024

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure. Image of a syringe on two vials highlights aripiprazole monohydrate LAI clinical use in Bipolar I Disorder.

Subscribe to read
more articles

Subscribe